Hepatitis in Pregnant Women and Children

Complete the EPID 394 form for patients who are currently infected with hepatitis B or hepatitis C and are:

1. currently pregnant, or

2. five years old or younger
   
   

Laboratory indication of current infection of hepatitis B and hepatitis C can include:

• Reactive Hepatitis C antibody

• Detected Hepatitis C RNA

• Reactive Hepatitis B Surface Antigen

For patients with Hepatitis C: If your patient’s reflex to Hepatitis C RNA resulted Not Detected,

the patient is not considered actively infected with hepatitis C and does not need to be reported

via EPID 394.

Please submit this form to the Local Health Department of the patient’s residence.

Perinatal Hepatitis B

Complete the EPID 399 form for infants who are born to a patient who had a reactive Hepatitis B

Surface Antigen test during their pregnancy or around the time of delivery.

If the mother did not have HBsAg testing during prenatal care or if results are not available,

please collect blood for HBsAg testing immediately after admission for delivery and review

results within 12 hours of birth.

To decrease the perinatal transmission of hepatitis B, all pregnant women in Kentucky must be

screened for hepatitis B surface antigen (HBsAg). State legislation mandating the testing

became effective July 15, 1998. Administrative regulation 902.KAR 2:020 requires all licensed

health professionals and facilities to report hepatitis B in a pregnant woman to the local or state

health department.

Hepatitis B and C

Complete the EPID 200 form for patients who meet case definition for Acute Hepatitis B or Acute Hepatitis

C per the Kentucky Department for Public Health:

Acute Hepatitis B:

• All positive labs that indicate an active Hepatitis B infection (except Anti-HBc Total and Anti-HBs) with ALT, Total Bilirubin, and/or presentation of jaundice
  
  

Acute Hepatitis C:

• Positive Hepatitis C Antibody AND Jaundice or Total Bilirubin ≥ 3.0 mg/dL or ALT > 200 IU/L

• Positive HCV RNA (qualitative, quantitative, or genotype test) AND Jaundice or Total Bilirubin ≥ 3.0 mg/dL or ALT > 200 IU/L

For patients with Hepatitis C: If your patient’s reflex to Hepatitis C RNA resulted Not Detected,

the patient is not considered actively infected with hepatitis C and does not need to be reported

via EPID 200.

If there is a more likely diagnosis which explains Jaundice, elevated Total Bilirubin, or elevated

ALT, please note under symptoms/comments.

Question about Hepatitis reporting?

Contact the NKY Health Epidemiology Department at epi.fax@nkyhealth.org or call our Hepatitis Epidemiologist 859-363-2066